BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 38584530)

  • 1. L-lysine Increases the Anticancer Effect of Doxorubicin in Breast Cancer by Inducing ROS-Dependent Autophagy.
    Jahani M; Yarani R; Rezazadeh D; Tahmasebi H; Hoseinkhani Z; Kiani S; Mansouri K
    Curr Cancer Drug Targets; 2024 Apr; ():. PubMed ID: 38584530
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of copper (I) nicotinate complex and autophagy modulation on doxorubicin-induced cytotoxicity in HCC1806 breast cancer cells.
    Abdel-Mohsen MA; Abdel Malak CA; El-Shafey ES
    Adv Med Sci; 2019 Mar; 64(1):202-209. PubMed ID: 30798072
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Src/STAT3-dependent heme oxygenase-1 induction mediates chemoresistance of breast cancer cells to doxorubicin by promoting autophagy.
    Tan Q; Wang H; Hu Y; Hu M; Li X; Aodengqimuge ; Ma Y; Wei C; Song L
    Cancer Sci; 2015 Aug; 106(8):1023-32. PubMed ID: 26041409
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro to Clinical Translation of Combinatorial Effects of Doxorubicin and Abemaciclib in Rb-Positive Triple Negative Breast Cancer: A Systems-Based Pharmacokinetic/Pharmacodynamic Modeling Approach.
    Fleisher B; Lezeau J; Werkman C; Jacobs B; Ait-Oudhia S
    Breast Cancer (Dove Med Press); 2021; 13():87-105. PubMed ID: 33628047
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thymoquinone Alterations of the Apoptotic Gene Expressions and Cell Cycle Arrest in Genetically Distinct Triple-Negative Breast Cancer Cells.
    Adinew GM; Messeha SS; Taka E; Badisa RB; Antonie LM; Soliman KFA
    Nutrients; 2022 May; 14(10):. PubMed ID: 35631261
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Excellent effects and possible mechanisms of action of a new antibody-drug conjugate against EGFR-positive triple-negative breast cancer.
    Zhou DD; Bai WQ; Zhai XT; Sun LP; Zhen YS; Li ZR; Miao QF
    Mil Med Res; 2021 Dec; 8(1):63. PubMed ID: 34879870
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sulforaphane induces autophagy by inhibition of HDAC6-mediated PTEN activation in triple negative breast cancer cells.
    Yang F; Wang F; Liu Y; Wang S; Li X; Huang Y; Xia Y; Cao C
    Life Sci; 2018 Nov; 213():149-157. PubMed ID: 30352240
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Yttrium Oxide nanoparticles induce cytotoxicity, genotoxicity, apoptosis, and ferroptosis in the human triple-negative breast cancer MDA-MB-231 cells.
    Emad B; WalyEldeen AA; Hassan H; Sharaky M; Abdelhamid IA; Ibrahim SA; Mohamed HR
    BMC Cancer; 2023 Nov; 23(1):1151. PubMed ID: 38012585
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combination Treatment with EGFR Inhibitor and Doxorubicin Synergistically Inhibits Proliferation of MCF-7 Cells and MDA-MB-231 Triple-Negative Breast Cancer Cells In Vitro.
    Abrahams B; Gerber A; Hiss DC
    Int J Mol Sci; 2024 Mar; 25(5):. PubMed ID: 38474312
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synergistic effect of photodynamic treatment and doxorubicin on triple negative breast cancer cells.
    Yousefi Sadeghloo A; Khorsandi K; Kianmehr Z
    Photochem Photobiol Sci; 2020 Nov; 19(11):1580-1589. PubMed ID: 33030191
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cholecalciferol-PEG Conjugate Based Nanomicelles of Doxorubicin for Treatment of Triple-Negative Breast Cancer.
    Kutlehria S; Behl G; Patel K; Doddapaneni R; Vhora I; Chowdhury N; Bagde A; Singh M
    AAPS PharmSciTech; 2018 Feb; 19(2):792-802. PubMed ID: 29019073
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Triptolide Decreases Cell Proliferation and Induces Cell Death in Triple Negative MDA-MB-231 Breast Cancer Cells.
    Varghese E; Samuel SM; Varghese S; Cheema S; Mamtani R; Büsselberg D
    Biomolecules; 2018 Dec; 8(4):. PubMed ID: 30563138
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synergistic effect of anethole and doxorubicin alleviates cell proliferation, cell cycle arrest, and ER stress and promotes ROS-mediated apoptosis in triple-negative breast cancer cells.
    Arumugam P; Sampathkumar B; Perumalsamy H; Balusamy SR; Ramesh V; Sundaravadevel S
    J Biochem Mol Toxicol; 2021 Dec; 35(12):e22928. PubMed ID: 34585488
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combination of the novel histone deacetylase inhibitor YCW1 and radiation induces autophagic cell death through the downregulation of BNIP3 in triple-negative breast cancer cells in vitro and in an orthotopic mouse model.
    Chiu HW; Yeh YL; Wang YC; Huang WJ; Ho SY; Lin P; Wang YJ
    Mol Cancer; 2016 Jun; 15(1):46. PubMed ID: 27286975
    [TBL] [Abstract][Full Text] [Related]  

  • 15. KIFC1: A Reliable Prognostic Biomarker in Rb-positive Triple-negative Breast Cancer Patients Treated With Doxorubicin in Combination With Abemaciclib.
    Fleisher B; Werkman C; Jacobs B; Varkey J; Taha K; Ait-Oudhia S
    Cancer Diagn Progn; 2022; 2(5):525-532. PubMed ID: 36060015
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blocking autophagy enhanced cytotoxicity induced by recombinant human arginase in triple-negative breast cancer cells.
    Wang Z; Shi X; Li Y; Fan J; Zeng X; Xian Z; Wang Z; Sun Y; Wang S; Song P; Zhao S; Hu H; Ju D
    Cell Death Dis; 2014 Dec; 5(12):e1563. PubMed ID: 25501824
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dillenia suffruticosa dichloromethane root extract induced apoptosis towards MDA-MB-231 triple-negative breast cancer cells.
    Foo JB; Saiful Yazan L; Tor YS; Wibowo A; Ismail N; Armania N; Cheah YK; Abdullah R
    J Ethnopharmacol; 2016 Jul; 187():195-204. PubMed ID: 27131434
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Danggui Buxue Tang improves therapeutic efficacy of doxorubicin in triple negative breast cancer via ferroptosis.
    Gong G; Ganesan K; Liu Y; Huang Y; Luo Y; Wang X; Zhang Z; Zheng Y
    J Ethnopharmacol; 2024 Apr; 323():117655. PubMed ID: 38158099
    [TBL] [Abstract][Full Text] [Related]  

  • 19. BAG3 Overexpression and Cytoprotective Autophagy Mediate Apoptosis Resistance in Chemoresistant Breast Cancer Cells.
    Das CK; Linder B; Bonn F; Rothweiler F; Dikic I; Michaelis M; Cinatl J; Mandal M; Kögel D
    Neoplasia; 2018 Mar; 20(3):263-279. PubMed ID: 29462756
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clarithromycin effectively enhances doxorubicin-induced cytotoxicity and apoptosis in MCF7 cells through dysregulation of autophagy.
    Amani N; Shokrzadeh M; Shaki F
    Adv Med Sci; 2020 Sep; 65(2):235-243. PubMed ID: 32252007
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.